Neil R. Ackerman

Neil R. Ackerman

Net worth: 4 M $ as of 31/05/2024

81 year
Health Technology
Consumer Services
Finance

Profile

Dr. Ackerman served in a variety of management positions at Cygnus, Inc from 1994-2005.
He initially led the development efforts for a number of transdermal products, two of which were approved.
He then led the R&D, clinical, regulatory and compliance functions for the Glucowatch Biographer, the first commercially available non-invasive glucose monitor.
From 1990-1994 he was Vice President, Research and Development at Glycomed, leading its discovery efforts in cardiovascular and inflammatory diseases.
From 1982-1990, he was Research Director, Cancer and Inflammatory Diseases with DuPont Pharmaceuticals.
Prior to that time, he had research and management positions at Syntex Corporation and Pfizer, Inc. He is currently an advisor to MMV Financial.
Dr. Ackerman received his Ph.D.
degree from the University of Maryland, and completed a post-doctoral fellowship in immunology at Stanford University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
05/05/2023 62,378 ( 0.01% ) 4 M $ 31/05/2024

Former positions of Neil R. Ackerman

CompaniesPositionEnd
Chief Tech/Sci/R&D Officer 01/04/2005
Corporate Officer/Principal -
See the detail of Neil R. Ackerman's experience

Training of Neil R. Ackerman

University of Maryland Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Neil R. Ackerman's experience

Connections

14

1st degree connections

3

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies2

Health Technology

Finance

See company connections
  1. Stock Market
  2. Insiders
  3. Neil R. Ackerman